黃冬梅
【摘要】 目的:觀察不同劑量的阿托伐他汀治療老年冠心病高脂血癥的療效及機制。方法:采集本院臨床120例患者分為觀察組和對照組,兩組均進行基礎治療,對照組在此基礎上給予辛伐他汀阿托伐他汀60 mg/d,1次/d,觀察組給予辛伐他汀阿托伐他汀40 mg/d,1次/d。觀察兩組患者血脂水平。結果:給藥后,兩組血脂水平均出現明顯降低,觀察組效果更為顯著,兩組比較差異有統計學意義(P<0.05)。觀察組不良反應發生情況僅為15.00%,而對照組為66.66%,兩組比較差異有統計學意義(P<0.05)。結論:給予40 mg劑量的辛伐他汀是治療老年患者的冠心病合并高脂血癥的最為安全有效的常規臨床劑量。
【關鍵詞】 冠心病; 高脂血癥; 辛伐他汀
Effect of Simvastatin Treatment for Elderly Coronary Heart Disease Patients with Hyperlipidemia/HUANG Dong-mei.//Medical Innovation of China,2014,11(28):067-069
【Abstract】 Objective: To observe the therapeutic effect and the mechanism of different dose of atorvastatin in treatment of elderly patients with coronary heart disease and hyperlipidemia. Method: 120 cases were divided into observation group and control group, the two groups were treated for infrastructure, control with simvastatin atorvastatin group 60 mg/d on the basis of this, the 1 time/d. The observation group was given simvastatin and atorvastatin 40 mg/d, 1 time/d. To observe changes of blood lipid levels in the two groups. Result: After administration, blood lipid levels of the two groups significantly decreased, the observation group effect was more obvious, with a significant difference between the two groups (P<0.05). The observation groups the incidence of adverse reactions was only 15%, which was higher than that of the observation group 66.66% (P<0.05). Conclusion: 40 mg in doses of simvastatin is the routine clinical dose is safe and effective for the treatment of coronary heart disease in elderly patients with hyperlipidemia.
【Key words】 Coronary heart disease; Hyperlipidemia; Simvastatin
First-authors address: Zibo City Combine Traditional Chinese and Western Medicine Hospital, Zibo 255026, China
doi:10.3969/j.issn.1674-4985.2014.28.024
高脂血癥的發病率隨著人們的生活水平的提高,大量的進食高脂高蛋白的食物,從而引起高血脂癥發病率升高的現象[1]。該病是動脈粥樣硬化、腦梗死、腎栓塞及冠心病的誘發因素。冠心病(CHD)中老年人常見的一種心血管疾病,本病的基本病變是供應心肌營養物質的血管冠狀動脈發生了粥樣硬化而臨床中最為多見的為冠心病合并高脂血癥的臨床情況[2]。尤其是老年人多發,也是由于血脂異常引起冠狀動脈粥樣硬化的一種常見慢性疾病[3]。早期應用血脂調節藥物糾正血脂代謝紊亂,對冠心病有較好的逆轉作用[4]。近年部分臨床證實,他汀類藥物能降低血脂水平并延緩或阻止動脈硬化發展,具有較好的抗炎、抗氧化應激等作用。但是對于老年患者這一特殊群體,不僅藥物治療效果重要,同時有效避免不良反應同樣要在臨床中引起重視,而本院常用辛伐他汀治療冠心病高脂血癥。本研究著重探討不同劑量的辛伐他汀對該疾病的效果以及安全性有無明顯差異,并為今后治療老年患者的冠心病高脂血癥提供較為有價值的用藥劑量參考依據。……